Financial Summary (All financials)
| In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 29.7 | 31.6 | 33.8 | 35.9 |
| Revenue growth | -6.2% | -6.4% | -5.8% | |
| Cost of goods sold | 16.7 | 16.8 | 16.1 | 14.3 |
| Gross profit | 13.0 | 14.8 | 17.7 | 21.5 |
| Gross margin | 43.9% | 46.8% | 52.2% | 60.1% |
| Sales and marketing | 6.6 | 7.4 | 10.9 | 13.0 |
| Research and development | 5.0 | 4.6 | 4.8 | 4.9 |
| General and administrative | 6.6 | 6.9 | 7.5 | 6.8 |
| EBITA | -4.5 | -4.3 | -5.9 | -3.4 |
| EBITA margin | -15.2% | -13.7% | -17.5% | -9.5% |
| Amortization of intangibles | 1.3 | 1.4 | | |
| EBIT | -5.8 | -5.8 | -5.9 | -3.4 |
| EBIT margin | -19.5% | -18.2% | -17.5% | -9.5% |
| Pre-tax income | -6.4 | -6.7 | -7.1 | -4.9 |
| Income taxes | 0.2 | -0.1 | 1.2 | 0.6 |
| Tax rate | | 1.7% | | |
| Net income | -6.6 | -6.6 | -8.3 | -5.5 |
| Net margin | -22.2% | -20.9% | -24.5% | -15.3% |
| |
| Diluted EPS | ($0.37) | ($0.37) | ($0.46) | ($0.34) |
| Shares outstanding (diluted) | 18.0 | 17.9 | 17.9 | 16.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|